Daiwa Securities Group Inc. Abbott Laboratories Transaction History

Daiwa Securities Group Inc.

$21.6 Billion
Q3 2024

A detailed history of Daiwa Securities Group Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 219,229 shares of ABT stock, worth $25.2 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

219,229

Previous 195,395 12.2%

Holding current value

$25.2 Million

Previous $20.3 Million 23.1%

% of portfolio

0.12%

Previous 0.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $2.39 Million - $2.82 Million	23,834 Added 12.2%	219,229 $25 Million
Q2 2024 Aug 07, 2024	BUY	$100.73 - $112.44 $1.8 Million - $2.01 Million	17,885 Added 10.08%	195,395 $20.3 Million
Q1 2024 May 02, 2024	BUY	$109.52 - $120.96 $1.7 Million - $1.87 Million	15,491 Added 9.56%	177,510 $20.2 Million
Q4 2023 Jan 31, 2024	BUY	$90.19 - $110.4 $910,287 - $1.11 Million	10,093 Added 6.64%	162,019 $17.8 Million
Q3 2023 Nov 01, 2023	BUY	$95.53 - $114.62 $1.03 Million - $1.24 Million	10,820 Added 7.67%	151,926 $14.7 Million
Q2 2023 Jul 31, 2023	BUY	$100.78 - $112.29 $463,285 - $516,197	4,597 Added 3.37%	141,106 $15.4 Million
Q1 2023 May 02, 2023	BUY	$96.86 - $114.01 $1 Million - $1.18 Million	10,340 Added 8.2%	136,509 $13.8 Million
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $745,080 - $874,093	7,838 Added 6.62%	126,169 $13.9 Million
Q3 2022 Nov 02, 2022	BUY	$96.76 - $112.03 $297,924 - $344,940	3,079 Added 2.67%	118,331 $11.5 Million
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $389,499 - $470,779	3,816 Added 3.42%	115,252 $12.5 Million
Q1 2022 Apr 29, 2022	BUY	$114.02 - $139.04 $128,158 - $156,280	1,124 Added 1.02%	111,436 $13.2 Million
Q4 2021 Feb 03, 2022	BUY	$115.53 - $141.46 $164,052 - $200,873	1,420 Added 1.3%	110,312 $15.5 Million
Q3 2021 Nov 05, 2021	BUY	$116.66 - $129.06 $527,769 - $583,867	4,524 Added 4.33%	108,892 $12.9 Million
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $5.91 Million - $6.96 Million	-55,905 Reduced 34.88%	104,368 $12.1 Million
Q1 2021 May 03, 2021	SELL	$108.84 - $128.23 $8.87 Million - $10.5 Million	-81,506 Reduced 33.71%	160,273 $19.2 Million
Q4 2020 Feb 04, 2021	SELL	$105.0 - $114.42 $435,225 - $474,270	-4,145 Reduced 1.69%	241,779 $26.5 Million
Q3 2020 Nov 02, 2020	BUY	$91.64 - $111.29 $2.1 Million - $2.55 Million	22,875 Added 10.26%	245,924 $26.8 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $272,764 - $398,856	4,342 Added 1.99%	223,049 $17.6 Million
Q4 2019 Jan 31, 2020	BUY	$78.51 - $87.4 $3.92 Million - $4.36 Million	49,893 Added 29.56%	218,707 $19 Million
Q3 2019 Nov 04, 2019	BUY	$81.84 - $88.74 $5.09 Million - $5.52 Million	62,185 Added 58.32%	168,814 $14.1 Million
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $597,907 - $697,340	-8,204 Reduced 7.14%	106,629 $8.97 Million
Q1 2019 Apr 26, 2019	BUY	$66.22 - $80.06 $95,224 - $115,126	1,438 Added 1.27%	114,833 $9.18 Million
Q4 2018 Feb 05, 2019	SELL	$65.56 - $74.27 $3.29 Million - $3.73 Million	-50,214 Reduced 30.69%	113,395 $8.2 Million
Q3 2018 Nov 01, 2018	SELL	$60.81 - $73.36 $367,474 - $443,314	-6,043 Reduced 3.56%	163,609 $12 Million
Q2 2018 Jul 30, 2018	BUY	$57.57 - $63.54 $954,971 - $1.05 Million	16,588 Added 10.84%	169,652 $10.3 Million
Q1 2018 May 02, 2018	BUY	$56.27 - $63.62 $498,833 - $563,991	8,865 Added 6.15%	153,064 $9.17 Million
Q4 2017 Feb 06, 2018	SELL	$53.68 - $57.47 $787,968 - $843,602	-14,679 Reduced 9.24%	144,199 $8.23 Million
Q3 2017 Nov 02, 2017	BUY	$48.06 - $53.64 $7.64 Million - $8.52 Million	158,878	158,878 $8.48 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.31B

Call Options Held

8.74M

Put Options Held

7.89M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Abbott Laboratories Transaction History